Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.10.0.1
Segment Information - Schedule of Segment Information (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Net revenues - External $ 3,292,217 $ 74,565 $ 758,830 $ 4,893,877 $ 758,830  
(Loss) income from operations (2,393,385) (3,915,063) (7,471,320) (6,105,408) (7,471,320)  
Depreciation and amortization 317,734 419,924 846,853 651,248 846,853  
Capital expenditures 214,147 $ 1,394,087    
Total assets 16,246,245     16,246,245   $ 6,290,794
Clinical Laboratory Operations [Member]            
Net revenues - External 114,736 74,565   160,321 758,830  
(Loss) income from operations (462,271) (1,477,754)   (1,218,354) (2,770,029)  
Depreciation and amortization 217,495 419,905   512,969 854,373  
Capital expenditures    
Total assets 789,278     789,278   1,503,520
Hospital Operations [Member]            
Net revenues - External 3,177,481   4,733,556  
(Loss) income from operations (1,231,764) (553,352)   (2,704,363) (1,020,668)  
Depreciation and amortization 99,991   137,717  
Capital expenditures 214,147   1,394,087  
Total assets 11,783,059     11,783,059   3,436,773
Corporate [Member]            
(Loss) income from operations (699,350) (1,884,287)   (2,182,691) (3,688,804)  
Depreciation and amortization 248 349   562 661  
Capital expenditures          
Total assets 5,446,170     5,446,170   255,566
Eliminations [Member]            
(Loss) income from operations 330   8,181  
Depreciation and amortization (330)   (8,181)  
Capital expenditures    
Total assets (3,506,174)     (3,506,174)   $ (1,454,569)
Supportive Software Solutions [Member]            
Total assets 1,697,042 2,549,504   1,697,042 2,549,504  
Decision Support and Informatics [Member]            
Total assets $ 36,870   $ 36,870